BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 28901012)

  • 1. Pharmacology of cognition: a panacea for neuropsychiatric disease?
    Bailey SJ; Neill JC; Moran PM
    Br J Pharmacol; 2017 Oct; 174(19):3133-3135. PubMed ID: 28901012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting inflammation to reduce cardiovascular disease risk.
    Maffia P; Cirino G
    Br J Pharmacol; 2017 Nov; 174(22):3895-3897. PubMed ID: 29080212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurosteroid biosynthesis down-regulation and changes in GABA
    Locci A; Pinna G
    Br J Pharmacol; 2017 Oct; 174(19):3226-3241. PubMed ID: 28456011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamatergic regulation of cognition and functional brain connectivity: insights from pharmacological, genetic and translational schizophrenia research.
    Dauvermann MR; Lee G; Dawson N
    Br J Pharmacol; 2017 Oct; 174(19):3136-3160. PubMed ID: 28626937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-species studies of cognition relevant to drug discovery: a translational approach.
    Robbins TW
    Br J Pharmacol; 2017 Oct; 174(19):3191-3199. PubMed ID: 28432778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updating neuropathology and neuropharmacology of monoaminergic systems.
    Ramsay RR; De Deurwaerdère P; Di Giovanni G
    Br J Pharmacol; 2016 Jul; 173(13):2065-8. PubMed ID: 27302283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive deficits caused by prefrontal cortical and hippocampal neural disinhibition.
    Bast T; Pezze M; McGarrity S
    Br J Pharmacol; 2017 Oct; 174(19):3211-3225. PubMed ID: 28477384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifestyle use of drugs by healthy people for enhancing cognition, creativity, motivation and pleasure.
    d'Angelo LC; Savulich G; Sahakian BJ
    Br J Pharmacol; 2017 Oct; 174(19):3257-3267. PubMed ID: 28427114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments in research of melatonin and its potential therapeutic applications.
    Stanford SC
    Br J Pharmacol; 2018 Aug; 175(16):3187-3189. PubMed ID: 30917240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WNT signalling: mechanisms and therapeutic opportunities.
    Schulte G; Bryja V
    Br J Pharmacol; 2017 Dec; 174(24):4543-4546. PubMed ID: 29235106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highlights into the pharmacology of nutraceuticals.
    Andrew R; Izzo AA
    Br J Pharmacol; 2020 Mar; 177(6):1209-1211. PubMed ID: 32133625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Principles of pharmacological research of nutraceuticals.
    Andrew R; Izzo AA
    Br J Pharmacol; 2017 Jun; 174(11):1177-1194. PubMed ID: 28500635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pharmacology of GPCRs.
    Langmead CJ; Summers RJ
    Br J Pharmacol; 2018 Nov; 175(21):4005-4008. PubMed ID: 30302756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of oxidative stress: translational opportunities.
    Daiber A; Di Lisa F; Ferdinandy P
    Br J Pharmacol; 2017 Jun; 174(12):1511-1513. PubMed ID: 28555779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pro-cognitive mechanisms of physical exercise in people with schizophrenia.
    Firth J; Cotter J; Carney R; Yung AR
    Br J Pharmacol; 2017 Oct; 174(19):3161-3172. PubMed ID: 28261797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial for GPR84 pharmacology.
    Milligan G
    Br J Pharmacol; 2024 May; 181(10):1497-1499. PubMed ID: 38456201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies.
    O'Tuathaigh CMP; Moran PM; Zhen XC; Waddington JL
    Br J Pharmacol; 2017 Oct; 174(19):3173-3190. PubMed ID: 28667666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress in the understanding of relaxin family peptides and their receptors.
    Summers RJ
    Br J Pharmacol; 2017 May; 174(10):915-920. PubMed ID: 28447360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms regulating perivascular adipose tissue - potential pharmacological targets?
    Kennedy S; Salt IP
    Br J Pharmacol; 2017 Oct; 174(20):3385-3387. PubMed ID: 28940457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into cardiotoxicity caused by chemotherapeutic agents.
    Grieve DJ; Davidson SM
    Br J Pharmacol; 2017 Nov; 174(21):3675-3676. PubMed ID: 29046013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.